Cargando…

Diagnostic value of the novel CMR parameter “myocardial transit-time” (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy

BACKGROUND: Coronary microvascular dysfunction (CMD) is present in various non-ischemic cardiomyopathies and in particular in those with left-ventricular hypertrophy. This study evaluated the diagnostic value of the novel cardiovascular magnetic resonance (CMR) parameter “myocardial transit-time” (M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chatzantonis, Grigorios, Bietenbeck, Michael, Florian, Anca, Meier, Claudia, Stalling, Philipp, Korthals, Dennis, Reinecke, Holger, Yilmaz, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806531/ https://www.ncbi.nlm.nih.gov/pubmed/32372287 http://dx.doi.org/10.1007/s00392-020-01661-6

Ejemplares similares

CMR-based T1-mapping offers superior diagnostic value compared to longitudinal strain-based assessment of relative apical sparing in cardiac amyloidosis
por: Korthals, Dennis, et al.
Publicado: (2021)

Introduction of a CMR-conditional cardiac phantom simulating cardiac anatomy and function and enabling training of interventional CMR procedures
por: Bietenbeck, Michael, et al.
Publicado: (2019)

Therapeutic value of tafamidis in patients with wild-type transthyretin amyloidosis (ATTRwt) with cardiomyopathy based on cardiovascular magnetic resonance (CMR) imaging
por: Chamling, Bishwas, et al.
Publicado: (2022)

Regression of cardiac amyloid load documented by cardiovascular magnetic resonance in a patient with hereditary amyloidosis
por: Florian, Anca, et al.
Publicado: (2020)

A compartment-based myocardial density approach helps to solve the native T1 vs. ECV paradox in cardiac amyloidosis
por: Chamling, Bishwas, et al.
Publicado: (2022)

Surprising diagnosis in a patient with acute coronary syndrome: a case report of acute streptococcal pharyngitis-associated perimyocarditis
por: Chatzantonis, Grigorios, et al.
Publicado: (2020)

A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients
por: Drakos, Stefanos, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-Associated Myocarditis: A Run of Bad Luck or Rather Deficient-Monitoring Protocol?
por: Chatzantonis, Grigorios, et al.
Publicado: (2020)

Clinical experience regarding safety and diagnostic value of cardiovascular magnetic resonance in patients with a subcutaneous implanted cardioverter/defibrillator (S-ICD) at 1.5 T
por: Holtstiege, Viktoria, et al.
Publicado: (2020)

Serial Cardiovascular Magnetic Resonance Studies Prior to and After mRNA-Based COVID-19 Booster Vaccination to Assess Booster-Associated Cardiac Effects
por: Meier, Claudia, et al.
Publicado: (2022)

Amyloidosis with phenotype of hypertrophic cardiomyopathy
por: Kuryła, Martyna, et al.
Publicado: (2023)

CMR assessment of hypertrophic cardiomyopathy with restrictive phenotype
por: Lu, Minjie, et al.
Publicado: (2015)

Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study
por: Chatzantonis, Grigorios, et al.
Publicado: (2020)

Microvascular Dysfunction in Hypertrophic Cardiomyopathy
por: Pelliccia, Francesco, et al.
Publicado: (2022)

CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Papavassiliu, Theano, et al.
Publicado: (2009)

Non-contrast T1rho CMR for hypertrophic cardiomyopathy
por: Wang, Chunhua, et al.
Publicado: (2015)

The clinical and CMR Characteristics of Hypertrophic Cardiomyopathy with Restrictive Phenotype
por: Lu, Minjie, et al.
Publicado: (2016)

Biatrial performance in children with hypertrophic cardiomyopathy: CMR study
por: Mazurkiewicz, Łukasz, et al.
Publicado: (2018)

CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy
por: Wang, Fangqing, et al.
Publicado: (2023)

Stress perfusion CMR in hypertrophic cardiomyopathy: comparison with late gadolinium enhancement
por: Villa, Adriana, et al.
Publicado: (2014)

The use of multiparametric CMR to predict impaired exercise capacity in hypertrophic cardiomyopathy
por: Flett, Andrew S, et al.
Publicado: (2009)

Coronary microvascular disease in hypertrophic and infiltrative cardiomyopathies
por: Giannopoulos, Andreas A., et al.
Publicado: (2022)

Cardiac amyloidosis and hypertrophic cardiomyopathy: A dangerous liaison
por: Ebrille, Elisa, et al.
Publicado: (2013)

Right ventricular obstructive hypertrophic cardiomyopathy in primary Myo-Adenylate Deaminase Deficiency
por: DE GREGORIO, C., et al.
Publicado: (2011)

Assessment of prognostic LV parameters with CMR in hypertrophic cardiomyopathy: impact of the papillary muscles
por: Gommans, Frank, et al.
Publicado: (2012)

Role of inflammation in the pathogenesis of hypertrophic cardiomyopathy: a T2-mapping CMR study
por: Ismail, Tevfik F, et al.
Publicado: (2012)

CMR derived MAPSE and TAPSE Measurements in hypertrophic cardiomyopathy: comparison to healthy volunteers
por: Abdel-Aty, Hassan, et al.
Publicado: (2012)

CMR detects abnormal septal convexity into the left ventricle in preclinical hypertrophic cardiomyopathy
por: Reant, Patricia, et al.
Publicado: (2015)

Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis?
por: Chamling, Bishwas, et al.
Publicado: (2021)

Cardiac Amyloidosis Masked as Hypertrophic Cardiomyopathy: A Case Report
por: Wang, Jing, et al.
Publicado: (2016)

Right Ventricle Outflow Obstruction in Biventricular Hypertrophic Cardiomyopathy in Amyloidosis
por: Sanoussi, Hamza, et al.
Publicado: (2017)

Diagnosis of Cardiac Involvement in Amyloid A Amyloidosis by Cardiovascular Magnetic Resonance Imaging
por: Chamling, Bishwas, et al.
Publicado: (2021)

Diagnosis and Management of a Cardiac Amyloidosis Case Mimicking Hypertrophic Cardiomyopathy
por: Sattar, Yasar, et al.
Publicado: (2018)

Refractory microvascular angina in hypertrophic cardiomyopathy: a novel therapy?
por: Cheng, Kevin, et al.
Publicado: (2022)

Direct mitral regurgitation quantification in hypertrophic cardiomyopathy using 4D flow CMR jet tracking: evaluation in comparison to conventional CMR
por: Gupta, Aakash N., et al.
Publicado: (2021)

Maximal left ventricular wall thickness: a comparison between CMR and echocardiography in hypertrophic cardiomyopathy
por: Corona-Villalobos, Celia P, et al.
Publicado: (2013)

CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy
por: Cavus, Ersin, et al.
Publicado: (2021)

A case series of double-chambered left ventricle detected by cardiovascular magnetic resonance
por: Meier, Claudia, et al.
Publicado: (2023)

Distinguishing Cardiac Amyloidosis and Hypertrophic Cardiomyopathy by Thickness and Myocardial Deformation of the Right Ventricle
por: Liu, Hui, et al.
Publicado: (2022)

Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy
por: Joy, George, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e4u7c3287hoq5t6foccn3ltvcr